2014
DOI: 10.1177/2150135113504309
|View full text |Cite
|
Sign up to set email alerts
|

Repeated Aortopulmonary Shunt Thrombosis in a Neonatal Patient With a Low Antithrombin Level

Abstract: A female infant with unbalanced right ventricular dominant atrioventricular septal defect with double-outlet right ventricle and pulmonary stenosis had recurrent aortopulmonary shunt thrombosis. She was found to have low antithrombin levels and was managed with antithrombin replacement in addition to unfractionated heparin. A subsequent aortopulmonary shunt was successfully placed, and patency was maintained. Her antithrombin levels normalized, and she was continued on low-molecular-weight heparin and aspirin … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…77 Antithrombin concentrate has been used to optimize heparin therapy and provide a more consistent state of anticoagulation during extracorporeal membrane oxygenation, cardiopulmonary bypass, and aortopulmonary shunt placement, without increasing the risk for excessive bleeding. 83,[107][108][109][110][111] Anticoagulation dosing in neonates is based on lower levels of antithrombin; therefore, if antithrombin concentrate is administered to achieve anticoagulation and the anticoagulant dose is not adjusted, significant bleeding complications may occur.…”
Section: Management Of Thrombosismentioning
confidence: 99%
See 1 more Smart Citation
“…77 Antithrombin concentrate has been used to optimize heparin therapy and provide a more consistent state of anticoagulation during extracorporeal membrane oxygenation, cardiopulmonary bypass, and aortopulmonary shunt placement, without increasing the risk for excessive bleeding. 83,[107][108][109][110][111] Anticoagulation dosing in neonates is based on lower levels of antithrombin; therefore, if antithrombin concentrate is administered to achieve anticoagulation and the anticoagulant dose is not adjusted, significant bleeding complications may occur.…”
Section: Management Of Thrombosismentioning
confidence: 99%
“…27 There are situations Lower levels of antithrombin in neonates with CHD may predispose aortopulmonary shunt thrombosis. 83 Complications of thrombosis in neonates with CHD include pulmonary embolism, stroke, hemorrhage, and cardiac failure. 84,85 Occurrence of thrombosis after pediatric cardiac surgery has been linked to a 3.4-fold increase in mortality.…”
Section: Management Of Thrombosismentioning
confidence: 99%